{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T15:42:58Z","timestamp":1792510978511,"version":"4.5.0"},"reference-count":36,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T00:00:00Z","timestamp":1675209600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T00:00:00Z","timestamp":1675209600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["jpet.aspetjournals.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Journal of Pharmacology and Experimental Therapeutics"],"published-print":{"date-parts":[[2023,2]]},"DOI":"10.1124\/jpet.122.001138","type":"journal-article","created":{"date-parts":[[2022,11,10]],"date-time":"2022-11-10T18:15:15Z","timestamp":1668104115000},"page":"296-305","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":10,"title":["The Effects of Indobufen on Micro-Inflammation and Peritoneal Transport Function in Patients Undergoing Continuous Ambulate Peritoneal Dialysis: A Prospective Randomized Controlled Study"],"prefix":"10.1016","volume":"384","author":[{"given":"Fang","family":"Liu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hao","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hong","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shikun","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianwen","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1124\/jpet.122.001138_bib1","doi-asserted-by":"crossref","DOI":"10.1016\/j.cellsig.2020.109778","article-title":"Molecular pathways in peritoneal fibrosis","volume":"75","author":"Balzer","year":"2020","journal-title":"Cell Signal"},{"key":"10.1124\/jpet.122.001138_bib2","doi-asserted-by":"crossref","first-page":"369","DOI":"10.2165\/00002512-200118050-00007","article-title":"Indobufen: an updated review of its use in the management of atherothrombosis","volume":"18","author":"Bhana","year":"2001","journal-title":"Drugs Aging"},{"key":"10.1124\/jpet.122.001138_bib3","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1159\/000494511","article-title":"Icodextrin is associated with a lower risk of stroke in peritoneal dialysis patients","volume":"141","author":"Chiu","year":"2019","journal-title":"Nephron"},{"key":"10.1124\/jpet.122.001138_bib4","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1093\/ndt\/gfn467","article-title":"Enhanced clearance of highly protein-bound drugs by albumin-supplemented dialysate during modeled continuous hemodialysis","volume":"24","author":"Churchwell","year":"2009","journal-title":"Nephrol Dial Transplant"},{"key":"10.1124\/jpet.122.001138_bib5","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.semnephrol.2016.10.004","article-title":"Peritoneal dialysis catheter insertion","volume":"37","author":"Crabtree","year":"2017","journal-title":"Semin Nephrol"},{"key":"10.1124\/jpet.122.001138_bib6","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1177\/0896860820970834","article-title":"ISPD guidelines for peritoneal dialysis in acute kidney injury: 2020 update (adults)","volume":"41","author":"Cullis","year":"2021","journal-title":"Perit Dial Int"},{"key":"10.1124\/jpet.122.001138_bib7","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1016\/j.cardiores.2005.07.013","article-title":"Indobufen inhibits tissue factor in human monocytes through a thromboxane-mediated mechanism","volume":"69","author":"Eligini","year":"2006","journal-title":"Cardiovasc Res"},{"key":"10.1124\/jpet.122.001138_bib8","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1007\/BF00558435","article-title":"Pharmacokinetic, bioavailability and pharmacodynamic study of indobufen (K 3920), an inhibitor of platelet aggregation, after a single dose in man","volume":"15","author":"Fuccella","year":"1979","journal-title":"Eur J Clin Pharmacol"},{"key":"10.1124\/jpet.122.001138_bib9","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1002\/chir.10137","article-title":"Protein binding of indobufen enantiomers: pharmacokinetics of free fraction-studies after single or multiple doses of rac-indobufen","volume":"14","author":"G\u0142\u00f3wka","year":"2002","journal-title":"Chirality"},{"key":"10.1124\/jpet.122.001138_bib10","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1038\/s41581-020-0315-4","article-title":"The current and future landscape of dialysis","volume":"16","author":"Himmelfarb","year":"2020","journal-title":"Nat Rev Nephrol"},{"key":"10.1124\/jpet.122.001138_bib11","doi-asserted-by":"crossref","first-page":"1423","DOI":"10.1007\/s11255-015-1015-z","article-title":"The use of mycophenolate mofetil in experimental encapsulating peritoneal sclerosis","volume":"47","author":"Huddam","year":"2015","journal-title":"Int Urol Nephrol"},{"key":"10.1124\/jpet.122.001138_bib12","doi-asserted-by":"crossref","first-page":"F167","DOI":"10.1152\/ajprenal.00052.2017","article-title":"TGF-\u03b21-VEGF-A pathway induces neoangiogenesis with peritoneal fibrosis in patients undergoing peritoneal dialysis","volume":"314","author":"Kariya","year":"2018","journal-title":"Am J Physiol Renal Physiol"},{"key":"10.1124\/jpet.122.001138_bib13","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1159\/000369588","article-title":"Cardiac, inflammatory and metabolic parameters: hemodialysis versus peritoneal dialysis","volume":"5","author":"Lai","year":"2015","journal-title":"Cardiorenal Med"},{"key":"10.1124\/jpet.122.001138_bib14","doi-asserted-by":"crossref","first-page":"2698","DOI":"10.1161\/01.CIR.0000131660.51520.9A","article-title":"Bidirectional relation between inflammation and coagulation","volume":"109","author":"Levi","year":"2004","journal-title":"Circulation"},{"key":"10.1124\/jpet.122.001138_bib15","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1007\/s11481-020-09978-9","article-title":"Pretreatment of indobufen and aspirin and their combinations with clopidogrel or ticagrelor alleviates inflammasome mediated pyroptosis via inhibiting NF-\u03baB\/NLRP3 pathway in ischemic stroke","volume":"16","author":"Li","year":"2021","journal-title":"J Neuroimmune Pharmacol"},{"key":"10.1124\/jpet.122.001138_bib16","article-title":"Low molecular weight heparin (LMWH) improves peritoneal function and inhibits peritoneal fibrosis possibly through suppression of HIF-1\u03b1, VEGF and TGF-\u03b21","volume":"10","author":"Li","year":"2015","journal-title":"PLoS One"},{"key":"10.1124\/jpet.122.001138_bib17","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1038\/nrneph.2016.181","article-title":"Changes in the worldwide epidemiology of peritoneal dialysis","volume":"13","author":"Li","year":"2017","journal-title":"Nat Rev Nephrol"},{"key":"10.1124\/jpet.122.001138_bib18","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/j.semnephrol.2016.10.007","article-title":"Inflammation and peritoneal dialysis","volume":"37","author":"Li","year":"2017","journal-title":"Semin Nephrol"},{"key":"10.1124\/jpet.122.001138_bib19","doi-asserted-by":"crossref","first-page":"1452","DOI":"10.3390\/molecules23061452","article-title":"Anticoagulant activities of indobufen, an antiplatelet drug","volume":"23","author":"Liu","year":"2018","journal-title":"Molecules"},{"key":"10.1124\/jpet.122.001138_bib20","doi-asserted-by":"crossref","first-page":"3566","DOI":"10.12659\/MSM.915590","article-title":"Comparison of the effects of indobufen and warfarin in a rat model of adenine-induced chronic kidney disease","volume":"25","author":"Lou","year":"2019","journal-title":"Med Sci Monit"},{"key":"10.1124\/jpet.122.001138_bib21","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1089\/ten.teb.2018.0157","article-title":"The bidirectional interactions between inflammation and coagulation in fracture hematoma","volume":"25","author":"Ma","year":"2019","journal-title":"Tissue Eng Part B Rev"},{"key":"10.1124\/jpet.122.001138_bib22","first-page":"S2","article-title":"Peritoneal membrane morphology and function","volume":"56","author":"Nagy","year":"1996","journal-title":"Kidney Int Suppl"},{"key":"10.1124\/jpet.122.001138_bib23","doi-asserted-by":"crossref","first-page":"199s","DOI":"10.1378\/chest.08-0672","article-title":"Antiplatelet drugs: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th edition)","volume":"133","author":"Patrono","year":"2008","journal-title":"Chest"},{"key":"10.1124\/jpet.122.001138_bib24","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1016\/j.kint.2018.03.014","article-title":"Targeting Toll-like receptors with soluble Toll-like receptor 2 prevents peritoneal dialysis solution-induced fibrosis","volume":"94","author":"Raby","year":"2018","journal-title":"Kidney Int"},{"key":"10.1124\/jpet.122.001138_bib25","first-page":"119","article-title":"Effect of renal insufficiency on the pharmacokinetics of indobufen","volume":"36","author":"Savazzi","year":"1984","journal-title":"Curr Ther Res Clin Exp"},{"key":"10.1124\/jpet.122.001138_bib26","first-page":"265","article-title":"Effect of age on the pharmacokinetics of indobufen","volume":"24","author":"Savazzi","year":"1986","journal-title":"Int J Clin Pharmacol Ther Toxicol"},{"key":"10.1124\/jpet.122.001138_bib27","first-page":"18","article-title":"[The thromboxane-synthesis inhibitor ibustrin in the treatment of diabetic angiopathies]","volume":"68","author":"Shestakova","year":"1996","journal-title":"Ter Arkh"},{"key":"10.1124\/jpet.122.001138_bib28","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1186\/s12882-018-0921-6","article-title":"Different patterns of inflammatory and angiogenic factors are associated with peritoneal small solute transport and peritoneal protein clearance in peritoneal dialysis patients","volume":"19","author":"Shi","year":"2018","journal-title":"BMC Nephrol"},{"key":"10.1124\/jpet.122.001138_bib29","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1007\/BF00558436","article-title":"Indobufen (K 3920), a new inhibitor of platelet aggregation: effect of food on bioavailability, pharmacokinetic and pharmacodynamic study during repeated oral administration to man","volume":"15","author":"Tamassia","year":"1979","journal-title":"Eur J Clin Pharmacol"},{"key":"10.1124\/jpet.122.001138_bib30","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1111\/hdi.12040","article-title":"Platelet-to-lymphocyte ratio better predicts inflammation than neutrophil-to-lymphocyte ratio in end-stage renal disease patients","volume":"17","author":"Turkmen","year":"2013","journal-title":"Hemodial Int"},{"key":"10.1124\/jpet.122.001138_bib31","doi-asserted-by":"crossref","first-page":"155","DOI":"10.3109\/0886022X.2011.641514","article-title":"The relationship between neutrophil-to-lymphocyte ratio and inflammation in end-stage renal disease patients","volume":"34","author":"Turkmen","year":"2012","journal-title":"Ren Fail"},{"key":"10.1124\/jpet.122.001138_bib32","doi-asserted-by":"crossref","first-page":"506","DOI":"10.3747\/pdi.2013.00317","article-title":"Oral astaxanthin supplementation prevents peritoneal fibrosis in rats","volume":"35","author":"Wakabayashi","year":"2015","journal-title":"Perit Dial Int"},{"key":"10.1124\/jpet.122.001138_bib33","doi-asserted-by":"crossref","first-page":"445","DOI":"10.2165\/00003495-199244030-00009","article-title":"Indobufen. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy in cerebral, peripheral and coronary vascular disease","volume":"44","author":"Wiseman","year":"1992","journal-title":"Drugs"},{"key":"10.1124\/jpet.122.001138_bib34","doi-asserted-by":"crossref","first-page":"1190","DOI":"10.1111\/jcmm.13393","article-title":"Autophagy promotes fibrosis and apoptosis in the peritoneum during long-term peritoneal dialysis","volume":"22","author":"Wu","year":"2018","journal-title":"J Cell Mol Med"},{"key":"10.1124\/jpet.122.001138_bib35","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1056\/NEJMoa020809","article-title":"Peritoneal dialysis and epithelial-to-mesenchymal transition of mesothelial cells","volume":"348","author":"Y\u00e1\u00f1ez-M\u00f3","year":"2003","journal-title":"N Engl J Med"},{"key":"10.1124\/jpet.122.001138_bib36","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1016\/j.kint.2016.03.040","article-title":"Preventing peritoneal membrane fibrosis in peritoneal dialysis patients","volume":"90","author":"Zhou","year":"2016","journal-title":"Kidney Int"}],"container-title":["The Journal of Pharmacology and Experimental Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022356524003987?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022356524003987?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1124\/jpet.122.001138","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,19]],"date-time":"2025-02-19T13:17:59Z","timestamp":1739971079000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022356524003987"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,2]]},"references-count":36,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2023,2]]}},"alternative-id":["S0022356524003987"],"URL":"https:\/\/doi.org\/10.1124\/jpet.122.001138","relation":{},"ISSN":["0022-3565"],"issn-type":[{"value":"0022-3565","type":"print"}],"subject":[],"published":{"date-parts":[[2023,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The Effects of Indobufen on Micro-Inflammation and Peritoneal Transport Function in Patients Undergoing Continuous Ambulate Peritoneal Dialysis: A Prospective Randomized Controlled Study","name":"articletitle","label":"Article Title"},{"value":"The Journal of Pharmacology and Experimental Therapeutics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1124\/jpet.122.001138","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 by The American Society for Pharmacology and Experimental Therapeutics","name":"copyright","label":"Copyright"}]}}